Results 111 to 120 of about 328,615 (242)

TOLERANCE AND EFFICACY OF COMBINED DIETHYLCARBAMAZINE AND ALBENDAZOLE FOR TREATMENT OF WUCHERERIA BANCROFTI AND INTESTINAL HELMINTH INFECTIONS IN HAITIAN CHILDREN [PDF]

open access: bronze, 2005
LeAnne M. Fox   +8 more
openalex   +1 more source

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial

open access: gold, 2022
Livingstone Tavul   +22 more
openalex   +2 more sources

Tropical pulmonary eosinophilia among expatriate Indian workers in Saudi Arabia: a case series

open access: yesThe Egyptian Journal of Bronchology
Background Tropical pulmonary eosinophilia (TPE) is an uncommon but important manifestation of lymphatic filarial infection, caused primarily by Wuchereria bancrofti, Brugia malayi, and Brugia timori.
Salah A. M. Ali   +4 more
doaj   +1 more source

On 'Analytical models for the patchy spread of plant disease'.

open access: yes, 2003
Epidemiologists are interested in using models that incorporate the effects of clustering in the spatial pattern of disease on epidemic dynamics. Bolker (1999, Bull. Math. Biol.
Filipe, JAN, Gilligan, CA, Maule, MM
core   +1 more source

Towards a Strategic Plan for Research to Support the Global Program to EIiminate Lymphatic FiIariasis: Summary of Immediate Needs and Opportunities for Research on Lymphatic Filariasis. 2.2 Essential tools – Drugs and Clinical Drug Trials [PDF]

open access: yes, 2004
A series of advances during the past decade transformed LF from a neglected disease of poor countries into a disease now recognized as potentially eradicable.
Bradley, M H, Kumaraswami, V
core  

Doxycycline Treatment ofBrugia malayi–Infected Persons Reduces Microfilaremia and Adverse Reactions after Diethylcarbamazine and Albendazole Treatment [PDF]

open access: bronze, 2008
Taniawati Supali   +8 more
openalex   +1 more source

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis

open access: gold, 2023
Nicholas Opoku   +16 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy